Close Menu

NEW YORK (GenomeWeb) – LGC today announced it has reached a deal to acquire Biosearch Technologies for an undisclosed amount. 

Based in Petaluma, Calif., Biosearch manufactures and supplies custom oligonucleotides and associated reagents to the medical diagnostics, research, and applied markets. Its products are used in molecular diagnostics and the applied and research sectors of the genomics space, LGC said, adding that Biosearch works with the world's top 12 molecular diagnostics firms. 

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A German shepherd called Nala has had her genome sequenced.

A coronavirus serology test garners Emergency Use Authorization from the US Food and Drug Administration, but the Los Angeles Times asks: how will tests like that be used?

Certain gene variants in conjunction with a healthy lifestyle may keep brains young, according to New Scientist.

In Science this week: increased CD8 T cell density and increased IFN-gamma response may indicate metastatic prostate cancer patients who will respond to immune checkpoint blockade therapy.